Format

Send to

Choose Destination
Mol Cells. 2012 Mar;33(3):259-67. doi: 10.1007/s10059-012-2227-z. Epub 2012 Feb 15.

CD99-dependent expansion of myeloid-derived suppressor cells and attenuation of graft-versus-host disease.

Author information

1
Department of Pathology, Seoul National University College of Medicine, Seoul 110-799, Korea.

Abstract

CD99 is involved in many cellular events, such as the generation of Hodgkin and Reed-Sternberg cells, T cell costimulation, and leukocyte transendothelial migration. However, these studies have been limited to in vitro or in vivo experiments using CD99-deficient cell lines or anti-CD99 antibodies. In the present study, using CD99-deficient mice established by the exchangeable gene trap method, we investigated the physiologic function of murine CD99. In a B6 splenocytes → bm12 graft-versus-host disease model, wild-type cells were minimally lethal, whereas all mice that received CD99-deficient donor cells developed an early and more severe pathology. Graftversus-host disease in these mice was associated with insufficient expansion of myeloid-derived suppressor cells. This was confirmed by experiments illustrating that the injection of wild-type donor cells depleted of Mac-1(+) cells led to an almost identical disease course as the CD99-deficient donor system. Therefore, these results suggest that CD99 plays a crucial role in the attenuation of graft-versus-host disease by regulating the expansion of myeloid-derived suppressor cells.

PMID:
22350746
PMCID:
PMC3887710
DOI:
10.1007/s10059-012-2227-z
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Publishing M2Community Icon for PubMed Central
Loading ...
Support Center